Join
Live feed
·
INSIDERFilingvia Quantisnow
Abeona Therapeutics Inc. logo

Chief Financial Officer Vazzano Joseph Walter sold $265,242 worth of shares (49,338 units at $5.38) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 518,437 units (SEC Form 4) to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABEO (Abeona Therapeutics Inc.) and more on Quantisnow.

Chief Financial Officer Vazzano Joseph Walter sold $265,242 worth of shares (49,338 units at $5.38) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 518,437 units (SEC Form 4) to cover taxes | Quantisnow